男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Sanofi moves to bolster innovation in China

By He Wei in Shanghai | chinadaily.com.cn | Updated: 2020-06-19 13:20
Share
Share - WeChat
Pius S. Hornstein, general manager for general medicines and country lead for Sanofi China and Cai Mingpo, founder and president of Cathay Capital on a celebration ceremony in Shanghai on Friday. [Photo provided to chinadaily.com.cn]

French pharmaceutical company Sanofi has announced that it is investing in a global venture capital fund to support worldwide innovation and technology development, especially in China, its second largest market.

The capital injection of an undisclosed amount in Cathay Innovation will serve to strengthen Sanofi's connection to innovative healthcare ecosystems and help the company better navigate China, its strategic priority for development and innovation, said Pius S. Hornstein, general manager for general medicines and country lead for Sanofi China.

Hornstein said the move is backed by the expectation that China will drive 30 percent of global GDP growth over the next decade, with the healthcare market expected to make up roughly 10 percent of this growth.

"From the Healthy China 2030 strategy and the recent national two sessions, we find that new infrastructure, new technologies and new healthcare have been re-emphasized by the Chinese government," he said.

"By exposing Cathay to healthcare and us to innovation in a global context, such an investment will be beneficial to us in the future."

By leveraging diversified expertise and capabilities of different industries, Cathay Innovation has built a unique platform where start-ups and industry leaders such as Sanofi can work together to create new transformative innovations for the society.

"We will work closely to leverage new emerging health trends by collaborating with the most promising start-ups in the health sector," said Cai Mingpo, founder and president of Cathay Capital, a company related to Cathay Innovation.

Sanofi has been steadily pushing ahead with digitalization in China. The company recently teamed up with Chinese app WeChat Work to professionalize interaction between employees in a local context.

Hornstein noted the company will be ready to digitize chronic disease management in the future.

"If we want to contribute to the Healthy China 2030 initiative, we need to join forces with the government to tackle the key things in healthcare, which is not only building hospitals…but also making the infrastructure even more powerful," he said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 西峡县| 肃北| 衡阳县| 林周县| 哈密市| 新兴县| 确山县| 南通市| 尼勒克县| 泌阳县| 浦东新区| 铜川市| 诏安县| 周口市| 建始县| 永州市| 罗江县| 兴城市| 湘乡市| 进贤县| 陆河县| 云南省| 武定县| 贺兰县| 乐平市| 阜宁县| 烟台市| 汝阳县| 莲花县| 宝清县| 方正县| 陈巴尔虎旗| 海丰县| 中牟县| 达孜县| 永康市| 花莲县| 高邑县| 祁阳县| 怀来县| 白银市|